CTT Pharmaceutical Holdings, Inc

Fastest Delivery of APIs with our patented dissolvable strips. OTCQB:CTTH

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharmaceutical Holdings, Inc.(OTCQB:CTTH) signs LOI with testing company for clinical trials and testing utilizing our patented technology.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma issues news release for a $10 million Equity Line of Credit and S-1 filing for the SEC.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CEO Issues Letter to Shareholders

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma issues news release on upcoming CEO letter to shareholders.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma has signed a contract for a $3 Million Equity Line Of Credit.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma Updates

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma's PCAOB Audit for 2024 has been successfully completed. CTT has audited financials for the past 3 years.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma Grant Update:

CTT is expecting to get necessary information about both NIH grants on or before May 16, 2025 and the NSF grant on or before May 6, 2025. There are currently no delays. If that changes CTT will notify shareholders accordingly.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CEO Issues News Release to Shareholders

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT will officially uplist to the OTCQB this morning. The CEO will issue a news release to shareholders Wednesday, March 12, 2025.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma recieved approval to uplist to the OTCQB.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

The OTC indicated to CTT Pharma that we will be getting more information about our uplisting to the OTCQB by early next week. CTT also found out this week that our NIH and NSF grants are not delayed.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma recieves intention to grant from the European Patent Office for diabetes drugs.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma gives update on NSF Grant

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma has added an Independent Director with NIH/NSF experience.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma has successfully submitted our application to the OTCQB. We anticipate a 3-4 week process to uplist to the OTCQB and will notify shareholders as we get closer.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma has lowered the company's authorized share count from 300 million to 150 million shares.

[CTT Pharmaceutical Holdings, Inc @CTT_Pharma]

CTT Pharma Submits additional NIH Grant and expects the NIH to make a decision in April.